AMENDMENT NO. 1 TO ROYALTY PURCHASE AND SALE AGREEMENTRoyalty Purchase and Sale Agreement • August 9th, 2018 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 1 TO ROYALTY PURCHASE AND SALE AGREEMENT AND BILL OF SALE dated as of August 2, 2018 (the “Amendment”) among DEPOMED, INC., a California corporation (“Depomed”), DEPO DR SUB, LLC, a Delaware limited liability company (the “Seller”, and together with Depomed, the “Selling Parties”), and PDL Investment Holdings, LLC, a Delaware limited liability company (as assignee of PDL BIOPHARMA, INC., the “Purchaser”)
ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as PurchaserRoyalty Purchase and Sale Agreement • March 3rd, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
This ROYALTY PURCHASE AND SALE AGREEMENT (this “Royalty Purchase and Sale Agreement”) dated as of October 18, 2013 is among Depomed, Inc., a California corporation (“Depomed”), Depo DR Sub, LLC, a Delaware limited liability company (the “Seller,” and together with Depomed, the “Selling Parties”) and PDL BioPharma, Inc., a Delaware corporation (the “Purchaser”).
ROYALTY PURCHASE AND SALE AGREEMENTRoyalty Purchase and Sale Agreement • February 25th, 2008 • International Royalty Corp • Gold and silver ores • British Columbia
KENNECOTT CANADA EXPLORATION INC., (“KCEI”) a Canadian corporation of 354 – 200 Granville Street, Vancouver, British Columbia, V6C 1S4, KENNECOTT EXPLORATION COMPANY (“KEX”) a Delaware corporation of 224 North 2200 West, Salt Lake City, UT 84116, RIO TINTO METALS LIMITED (No. 147115) (“RTM”) whose registered office is at 6 St. James’s Square, London, England, RIO TINTO EXPLORATION PTY LIMITED (ABN 76 000 057 125) (“RTE”) of 37 Belmont Avenue, Belmont, Western Australia, Australia and ASHTON MINING LIMITED (ABN 16 005 466 964) (“AML”) of 2 Kings Park Road, West Perth, Western Australia, Australia
ROYALTY PURCHASE AND SALE AGREEMENT Between BARRICK GOLD CORPORATION - and - ROYAL GOLD, INC. July 30, 2008Royalty Purchase and Sale Agreement • August 20th, 2008 • Royal Gold Inc • Mineral royalty traders • Ontario
WHEREAS Purchaser has submitted a binding offer to Barrick to acquire the portfolio of Purchased Royalties (as defined below) of Barrick and its Affiliates in respect of which Barrick sought acquisition proposals;
ROYALTY PURCHASE AND SALE AGREEMENT dated as of October 18, 2013 between DEPOMED, INC., DEPO DR SUB, LLC, as Seller, and PDL BIOPHARMA, INC., as PurchaserRoyalty Purchase and Sale Agreement • March 17th, 2014 • Depomed Inc • Pharmaceutical preparations • New York
This ROYALTY PURCHASE AND SALE AGREEMENT (this “Royalty Purchase and Sale Agreement”) dated as of October 18, 2013 is among Depomed, Inc., a California corporation (“Depomed”), Depo DR Sub, LLC, a Delaware limited liability company (the “Seller,” and together with Depomed, the “Selling Parties”) and PDL BioPharma, Inc., a Delaware corporation (the “Purchaser”).
